First session of Saturday's session of #VTA23 - Dr Jacqui Brown on 'Personalised Fluid Management' #critcare#FOAMcc
The first buffered IV fluids were administed during the cholera epidemic in the UK in 1832. However, fluid therapy only entered main stream medical practice around the first world war. #VTA23
However, some time has passed since then. We have entered the era of personalised on individualised fluid management. There are many paradigms that can assist with this - ROSE, 7 D's, etc... #VTA23
Some NB definitions
Fluid Bolus - a volume of fluid given to a patient
Fluid Challenge - dynamic fluid challenge - a rapid administration of small amount of fluid to assess fluid responsiveness.
Fluid Responsiveness - an increase in cardiac output >10% after a bolus #VTA23
Fluid Tolerance - the degree to which a patient can tolerate administration of fluids
Fluid Accumulation Syndrome - cumulative accumulation of fluid resulting in organ dysfunction
Fluid Overload - >10% accumulation of fluid, based on baseline body weight doi.org/10.1016/j.jcrc…
ROSE - Phases of Fluid Administration
Resuscitation Phase - this is the phase of patient rescue. The trigger for starting fluid here is the presence of shock - whether sepsis, burns, etc...
Time is short (minutes), but you end up with a fluid balance. #VTA23
Optimisation Phase - here you have organ rescue, focus is on maintaining tissue perfusion and preventing fluid overload. Guided by fluid responsiveness. The trigger to decrease fluids - unresponsiveness. #VTA23
Stabilisation Phase - here you have organ support. Conservative fluid management is instituted for maintenance and replacement. The idea is to achieve negative fluid balance. #VTA23
Evacuation Phase - organ recovery is occurring. Stopping IV fluids and fluid removal (either passive or active) and a negative fluid balance are key. #VTA23
The concept of Fluid Stewardship emerges. Treating the fluid like a valuable drug, and preventing overuse and misuse.
This has been encapsulated into the 7 Ds by the International Fluid Academy: fluidacademy.org doi.org/10.1016/j.kint… #VTA23#fluidisadrug
What are our basal maintenance requirements
- Water - 1ml/kg/hr
- Glucose - 1-1.5mg/kg/hr
Remember that the fluid gained from 'fluid creep' should count towards this when looking at your maintenance infusions. #VTA23
Drug - Fluid Composition
The ideal fluid doesn't exist. What you need depends on the phase of fluid therapy, and the particular characteristics of the patient. The pharmacokinetics and pharmacodynamics of fluids should be kept in mind. #VTA23
Its important to remember whether a particular fluid is hypotonic, isotonic or hypertonic.
Hypotonic - e.g. 5% DW
Isotonic - e.g. 0.9% NaCl, Buffered solutions such as Ringer's Lactate or Balsol
Hypertonic - e.g. 3% NaCl #VTA23
Regarding buffered solution, which have decreased chloride that is replaced by another anion such as lactate, acetate or bicarbonate, in order to maintain electr
SMART and SALTED showed decreased renal adverse events and worse mortality with these vs 0.9% NaCl. #VTA23
De-escalation - Decreasing the amount of fluid administration.
De-resuscitation - Active fluid removal in patients with fluid overload. #VTA23
Why do we put tracheostomies in patients though?
The rationale for a trachy in ICU is that there are respiratory mechanical benefit (compare to a tracheal tube and a native airway). There are many patient care benefits - oral care, feeding, etc... #VTA23
There are problems, including the potential for real patient harm. Tracheostomy emergencies are a problem. Complications (Immediate, Early and Late) are encountered in 30% of patients. #VTA23
Next is Donna Hamel, speaking on 'PEEP Titration and Recruitment' #VTA23#critcare#FOAMcc
PEEP is important - it improves oxygenation, and is an essential component of lung protective strategies.
But PEEP also has some problems - it can cause hypotension and increased pulmonary vascular resistance.
So how does one get optimal PEEP? #VTA23
Optimal PEEP has no clear universal definition.
Maybe we should look for appropriate PEEP - a PEEP value that results in adequate oxygenation with the lowest risk of overdistension. #VTA23
Prof Anthony Holley is speaking next on 'Respiratory Support in the Trauma Patient' #VTA23#critcare#FOAMcc
The 'trauma' patient is not a single disease entity, but ultimately a mechanism that is characterised by a shared multitude of pathophysiological patterns (TBI, lung contusion, etc...) and interventions (surgery, transfusion) that lead to some common disease processes. #VTA23
These common disease processes include TRALI, ARDS, TIC and many more.
Of concern, ARDS is not uncommon in trauma patients. #VTA23
Next up are two of the Occupational Therapists from CHBAH - Marche van der Heyden and Tiffany Fairbairn - speaking on 'Sensory Stimulation in Critical Care'. #VTA23#critcare#FOAMcc
Sensory stimulation is emerging in critical care as a modality to re-establish normal functioning. Our senses are our connection to the world. There are 8 (not 5!) senses - auditory, olfactory, gustatory, visual, tactile/touch, vestibular, proprioception and interoception. #VTA23
The lesser known of these - vestibular, proprioception and interoception - all are key in self-soothing...
Interoception is the sense how different parts of our 'deep' body are feeling. There are a few activities that include all 8 senses - for example eating. #VTA23
Midmorning #VTA23 session starting - lots of short talks so expect quick changes in topic! #critcare#FOAMcc
Michael Gentile - Is PARDIE Changing Our View of Paediatric ARDS? #VTA23#FOAMcc#critcare
PARDIE stands for Pediatric ARDS Incidence and Epidemiology study. This study is one of the results of the PALISI Conference Group. doi.org/10.1016/S2213-… #VTA23
Last up for the morning session is John Davies, who is talking about 'Mechanical Ventilation during ECMO: all, some or none'. #VTA23#FOAMcc#critcare
Essential to remember the components of lung protective ventilation - tidal volume, plateau pressure, respiratory rate, PEEP, FiO2. #VTA23
Do the rules of LPV change when the patient is on ECMO.
There is little doubt that (in appropriately selected patients) ECMO has a mortality benefit. Have a look at the CESAR and EOLIA trials: doi.org/10.1016/S0140-… doi.org/10.1056/NEJMoa… #VTA23